Document is current
Any future updates will be listed below
-
Authors
Sato, Takeo
Tsuchimochi, Yuka
Hamada, Yuki
Kukihara, Kaishi
Kawabata, Yutaro
Iwamoto, Kana
Takaguchi, Go
Higuchi, Yujiro
Matsuoka, Hideki
Takashima, Hiroshi
- License Information
-
More Information
Article History
Received: 4 July 2025
Revised: 5 November 2025
Accepted: 16 November 2025
First Online: 10 December 2025
Compliance with ethical standards
:
: TS: reports lecture and travel fees from Pfizer Japan Inc. and lecture fees from Kowa Co., Ltd., and Daiichi Sankyo Co., Ltd. outside the submitted work. YT: none. YH: reports lecture fees from Daiichi Sankyo Co. Ltd., Medtronic Co. Ltd., Medico’s Hirata Co. Ltd., Johnson & Johnson Co. Ltd., Merit Medical Systems Inc., and Kaneka Co. Ltd. outside the submitted work. KK: none. YK: none. KI: none. GT: none. YH: none. HM: reports lecture fees from Daiichi Sankyo Co. Ltd., Pfizer Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kowa Co. Ltd., UCB Japan Co. Ltd., Novartis Pharma Co. Ltd., and AstraZeneca Co. Ltd. outside the submitted work. HT: reports lecture fees from Daiichi Sankyo Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Biogen Japan Ltd., Eisai Co. Ltd., FP Pharmaceutical Corp., Alnylam Pharmaceuticals Inc., Kyowa Kirin Co. Ltd., Alexion Pharmaceuticals Inc., argenx Japan K.K., CYBERDYNE Inc., Takeda Pharmaceutical Co. Ltd., CSL Behring K.K., Asahi Kasei Medical Co. Ltd., Chugai Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Amgen Inc., Japan Blood Products Organization, Cosmic Corporation Co. Ltd., and ONO PHARMACEUTICAL Co. Ltd. outside the submitted work. HT also reports scholarship donations from SHIN NIPPON BIOMEDICAL LABORATORIES Ltd. and Asahi Kasei Medical Co. Ltd. outside the submitted work.
